Guideline for the diagnosis and management of vitiligo

This detailed and user‐friendly guideline for the diagnosis and management of vitiligo in children and adults aims to give high quality clinical advice, based on the best available evidence and expert consensus, taking into account patient choice and clinical expertise.

[1]  R. Wolf,et al.  Comparison of two surgical approaches for treating vitiligo: a preliminary study , 2002, International journal of dermatology.

[2]  P. Christova,et al.  Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA , 2004, Clinical and experimental dermatology.

[3]  J. Fulton,et al.  Utilizing the Ultraviolet (UV Detect) Camera to Enhance the Appearance of Photodamage and Other Skin Conditions , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  H. Y. Kim,et al.  Epidermal grafts for treatment of stable and progressive vitiligo. , 1999, Journal of the American Academy of Dermatology.

[5]  D. Ashcroft,et al.  Interventions for vitiligo: a Cochrane systematic review , 2006 .

[6]  B. Moncada,et al.  A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. , 2003, Archives of Dermatology.

[7]  N. Lowe,et al.  Q-switched ruby laser. Further observations on treatment of professional tattoos. , 1994, The Journal of dermatologic surgery and oncology.

[8]  E. Bröcker,et al.  Narrow‐band UVB311 nm vs. broad‐band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo , 2005, International journal of dermatology.

[9]  S. Mulekar.  Stable Vitiligo Treated by a Combination of Low‐Dose Oral Pulse Betamethasone and Autologous, Noncultured Melanocyte‐Keratinocyte Cell Transplantation , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[10]  K. Thomsen,et al.  Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. , 1977, Archives of dermatology.

[11]  K. Saedi,et al.  The efficacy of combined PUVA and low‐dose azathioprine for early and enhanced repigmentation in vitiligo patients , 2006, The Journal of dermatological treatment.

[12]  K. thestrup-pedersen,et al.  PUVA treatment of vitiligo: a retrospective study of 59 patients. , 1992, Acta dermato-venereologica.

[13]  J. Naeyaert,et al.  Quality of Life and Stigmatization Profile in a Cohort of Vitiligo Patients and Effect of the Use of Camouflage , 2005, Dermatology.

[14]  J. Naeyaert,et al.  Topical pimecrolimus in the treatment of vitiligo. , 2007, European journal of dermatology : EJD.

[15]  R. Cancedda,et al.  Treatment of "stable" vitiligo by Timedsurgery and transplantation of cultured epidermal autografts. , 2000, Archives of dermatology.

[16]  K. Schallreuter,et al.  Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC‐KUS) , 2002, International journal of dermatology.

[17]  Soo Min Kim,et al.  The efficacy of low‐dose oral corticosteroids in the treatment of vitiligo patients , 1999, International journal of dermatology.

[18]  G. Singh,et al.  Vitiligo and intralesional steroids. , 1979, The Indian journal of medical research.

[19]  D. Ashcroft,et al.  Interventions for vitiligo. , 2006, The Cochrane database of systematic reviews.

[20]  E. Alpsoy,et al.  Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo‐controlled double‐blind study , 2001, The British journal of dermatology.

[21]  Aurel O. Iuga,et al.  Treatment of vitiligo with broadband ultraviolet B and vitamins , 2006, International journal of dermatology.

[22]  P. Flaxman,et al.  Different shades of meaning: Illness beliefs among vitiligo sufferers , 2002 .

[23]  D. Gawkrodger,et al.  Management of vitiligo , 2000, Clinical and experimental dermatology.

[24]  J. Wood,et al.  Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. , 1995, Dermatology.

[25]  L. Papadopoulos,et al.  Psychological factors in cutaneous disease : an overview of research , 1999 .

[26]  D. Parsad,et al.  Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo , 2003, Clinical and experimental dermatology.

[27]  C. Walker,et al.  Living with Vitiligo: A Controlled Investigation into the Effects of Group Cognitive-Behavioural and Person-Centred Therapies , 2004, Dermatology and Psychosomatics / Dermatologie und Psychosomatik.

[28]  S. Mattoo,et al.  Psychiatric morbidity in vitiligo: prevalence and correlates in India , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[29]  M. Sekla.  TREATMENT of vitiligo. , 1952, Lancet.

[30]  D. Buckley,et al.  Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo , 1996, Clinical and experimental dermatology.

[31]  J. N. Barbhuiya,et al.  The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patient. , 2003, Indian journal of dermatology, venereology and leprology.

[32]  W. Westerhof,et al.  Toxicology and health risks of hydroquinone in skin lightening formulations , 2005 .

[33]  M. Chren,et al.  Association Between Poorer Quality of Life and Psychiatric Morbidity in Patients With Different Dermatological Conditions , 2004, Psychosomatic medicine.

[34]  Jonathan A. Smith,et al.  Living with vitiligo: dealing with difference. , 2002, British journal of health psychology.

[35]  L. Perfetti,et al.  Photochemotherapy with topical khellin and sunlight in vitiligo. , 1992, Dermatology.

[36]  P. Bossuyt,et al.  A systematic review of autologous transplantation methods in vitiligo. , 1998, Archives of dermatology.

[37]  Vinod K. Sharma,et al.  Comparison of Minipunch Grafting versus Split‐Skin Grafting in Chronic Stable Vitiligo , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[38]  H. Kerl,et al.  The efficacy of excimer laser (308 nm) for vitiligo at different body sites , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[39]  P. Grimes,et al.  How we treat vitiligo. , 1983, Cutis.

[40]  R. Phelps,et al.  Combined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo: A Pilot Study , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[41]  W. Westerhof,et al.  Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo. , 1999, Archives of dermatology.

[42]  N. Fallah,et al.  What patients with vitiligo believe about their condition , 2004, International journal of dermatology.

[43]  S. Hann,et al.  The progression of nonsegmental vitiligo: clinical analysis of 318 patients , 1997, International journal of dermatology.

[44]  E. Hernández-Pérez.  VITILIGO TREATED WITH ACTH , 1979, International journal of dermatology.

[45]  S. Ugurel,et al.  Use of high‐dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo , 2000, International journal of dermatology.

[46]  J. Nordlund,et al.  Personal responses of patients to vitiligo: the importance of the patient-physician interaction. , 1978, Archives of dermatology.

[47]  L. Juhlin,et al.  Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. , 1997, Acta dermato-venereologica.

[48]  F. Aydın,et al.  Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[49]  A. Karaduman,et al.  No additional effect of topical calcipotriol on narrow‐band UVB phototherapy in patients with generalized vitiligo , 2005, Photodermatology, photoimmunology & photomedicine.

[50]  J. Hawk,et al.  Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. , 2007, Archives of dermatology.

[51]  R. Pandhi,et al.  Vitiligo: A Retrospective Comparative Analysis of Treatment Modalities in 500 Patients , 2001, The Journal of dermatology.

[52]  J. Naeyaert,et al.  Effect of vitiligo on self‐reported health‐related quality of life , 2005, The British journal of dermatology.

[53]  J. Shapiro,et al.  Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. , 2004, Archives of dermatology.

[54]  L. Andreassi,et al.  Autologous Epidermal Cultures and Narrow‐Band Ultraviolet B in the Surgical Treatment of Vitiligo , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[55]  A. Ben Hamida,et al.  Calcipotriol and PUVA as treatment for vitiligo. , 2003, Dermatology online journal.

[56]  T. Fitzpatrick,et al.  Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. , 1984, National Cancer Institute monograph.

[57]  R. Halder,et al.  Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. , 1995, Archives of dermatology.

[58]  C. Vervaet,et al.  Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. , 2004, Archives of dermatology.

[59]  Henry W. Lim,et al.  Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo , 2004, Photodermatology, photoimmunology & photomedicine.

[60]  Megan E. Pahmier,et al.  Double Blind , 2001, International Psychogeriatrics.

[61]  P. Majumder,et al.  Recent investigations on vitiligo vulgaris. , 1997, Dermatologic clinics.

[62]  M. Picardo,et al.  Tacalcitol and narrow‐band phototherapy in patients with vitiligo , 2006, Clinical and experimental dermatology.

[63]  G. Monfrecola,et al.  Ineffectiveness of topical khellin in photochemotherapy of vitiligo , 1995 .

[64]  L. Papadopoulos,et al.  Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. , 1999, The British journal of medical psychology.

[65]  J. Naeyaert,et al.  Autologous transplantation techniques for vitiligo: how to evaluate treatment outcome. , 2004, European journal of dermatology : EJD.

[66]  D. Parsad,et al.  Combination of PUVAsol and Topical Calcipotriol in Vitiligo , 1998, Dermatology.

[67]  R. Clayton.  A double‐blind trial of 0.05% clobetasol proprionate in the treatment of vitiligo , 1977, The British journal of dermatology.

[68]  A. MONEM EL MOFTY.  A preliminary clinical report on the treatment of leucodermia with Ammi majus Linn. , 1948, The Journal of the Egyptian Medical Association.

[69]  A. Erel,et al.  Is the combination of calcipotriol and PUVA effective in vitiligo? , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[70]  R. Singh,et al.  Psychiatric Morbidity in Psoriasis and Vitiligo: A Comparative Study , 2001, The Journal of dermatology.

[71]  U. Wollina,et al.  Psoralen plus ultraviolet A irradiation‐induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin , 2004, Clinical and experimental dermatology.

[72]  M. Picardo,et al.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. , 2007, Pigment cell research.

[73]  Ys. Lee,et al.  Squamous cell carcinoma in vitiligo lesion after long‐term PUVA therapy , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[74]  P. Grimes,et al.  The safety of hydroquinone , 2006, Journal of cosmetic dermatology.

[75]  L Juhlin,et al.  Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. , 2002, Acta dermato-venereologica.

[76]  Akira Yanai.  ERBIUM-YAG LASER , 2002 .

[77]  J. Ortonne,et al.  Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. , 2004, Archives of dermatology.

[78]  Bela J. Shah,et al.  A study of autologous melanocyte transfer in treatment of stable vitiligo. , 2005, Indian journal of dermatology, venereology and leprology.

[79]  D. Gawkrodger,et al.  Vitiligo presentation in adults , 2005, Clinical and experimental dermatology.

[80]  P. Majumder,et al.  Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. , 1994, American journal of human genetics.

[81]  S. Vora,et al.  Comparative stydy of various drug regimens in vitiligo , 1993 .

[82]  W. Westerhof,et al.  Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. , 1997, Archives of dermatology.

[83]  J. Porter,et al.  Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. , 1991, Journal of health and social behavior.

[84]  W. Westerhof,et al.  Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. , 2000, Journal of the American Academy of Dermatology.

[85]  A. Ehlers,et al.  Measuring adjustment to chronic skin disorders: validation of a self-report measure. , 2003, Psychological assessment.

[86]  D. Hu,et al.  Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. , 2004, Journal of the American Academy of Dermatology.

[87]  R. Stern,et al.  Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. , 1988, The Journal of investigative dermatology.

[88]  S. Frankel,et al.  Non-melanoma Skin Cancer , 2021, Surgical Oncology Manual.

[89]  G. Pellegrini,et al.  Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis , 2004, The British journal of dermatology.

[90]  K. Schallreuter,et al.  PUVA for vitiligo and skin cancer. , 1997, Clincal and Experimental Dermatology.

[91]  W. Westerhof,et al.  Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. , 2000, Journal of the American Academy of Dermatology.

[92]  Y. Saral,et al.  Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo. , 2005, European journal of dermatology : EJD.

[93]  J. Ajmeri,et al.  Treatment of vitiligo with the 308-nm excimer laser: a pilot study. , 2002, Journal of the American Academy of Dermatology.

[94]  G. Kent,et al.  Psychologic effects of vitiligo: a critical incident analysis. , 1996, Journal of the American Academy of Dermatology.

[95]  V. Sehgal.  A Comparative Clinical Evaluation of Trimethylpsoralen, Psoralen and 8‐methoxypsoralen in Treating Vitiligo , 1975, International journal of dermatology.

[96]  J. Bolognia,et al.  Depigmentation therapy , 2001 .

[97]  A. Chu,et al.  Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo , 2001, The British journal of dermatology.

[98]  A. Ilchyshyn,et al.  Concurrent Sweet's syndrome (acute febrile neutrophilic dermatosis), erythema nodosum and sarcoidosis. , 1997, Clinical and experimental dermatology.

[99]  M. Al-Khawajah.  The failure of L-phenylalanine and UVA in the treatment of vitiligo , 1996 .

[100]  Bhushan Kumar,et al.  Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. , 2003, Journal of the American Academy of Dermatology.

[101]  A. Alzate,et al.  An epidemiologic case-control study in a population with vitiligo. , 1995, Journal of the American Academy of Dermatology.

[102]  C. L. Callahan,et al.  The quality of life. , 1970, Nursing outlook.

[103]  H. Tagami,et al.  Treatment of vitiligo with oral corticosteroids. , 1976, Dermatologica.

[104]  G. Pellegrini,et al.  Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. , 2003, Archives of dermatology.

[105]  C. Chiaverini,et al.  Treatment of vitiligo by topical calcipotriol , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[106]  B. Khaitan,et al.  ORAL MINI‐PULSE THERAPY WITH BETAMETHASONE IN VITILIGO PATIENTS HAVING EXTENSIVE OR FAST‐SPREADING DISEASE , 1993, International journal of dermatology.

[107]  J. Pasricha,et al.  EFFECT OF PROLONGED TREATMENT WITH LEVAMISOLE ON VITILIGO WITH LIMITED AND SLOW‐SPREADING DISEASE , 1994, International Journal of Dermatology.

[108]  A. Finlay,et al.  DLQI scores in vitiligo: reliability and validity of the Persian version , 2004, BMC dermatology.

[109]  E. Kandil.  Treatment of vitiligo with O·1% betamethasone 17‐valerate in isopropyl alcohol—a double‐blind trial , 1974 .

[110]  M. Kumaran,et al.  Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo , 2006, Journal of the European Academy of Dermatology and Venereology.

[111]  G. Kent,et al.  Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers , 1996, Clinical and experimental dermatology.

[112]  F. Farah,et al.  THE TREATMENT OF VITILIGO WITH PSORALENS AND TRIAMCINOLONE BY MOUTH , 1967, The British journal of dermatology.

[113]  M. Rapaport.  Topical tacrolimus. , 2005, Archives of dermatology.

[114]  S. Dogra,et al.  Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome , 2003, The British journal of dermatology.

[115]  H. Hönigsmann,et al.  Oral dexamethasone pulse treatment for vitiligo. , 2001, Journal of the American Academy of Dermatology.

[116]  E. Kandil.  Treatment of vitiligo with 0-1 per cent betamethasone 17-valerate in isopropyl alcohol--a double-blind trial. , 1974, The British journal of dermatology.

[117]  G. Mujtaba,et al.  COMPARISON OF 0.05% CLOBETASOL PROPIONATE CREAM AND TOPICAL PUVASOL IN CHILDHOOD VITILIGO , 1995, International journal of dermatology.

[118]  D. Parsad,et al.  Comparison of systemic PUVA and NB‐UVB in the treatment of vitiligo: an open prospective study , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[119]  G. Kent.  Correlates of perceived stigma in vitiligo , 1999 .

[120]  Evon M. O. Abu-Taieh,et al.  Comparative Study , 2020, Definitions.

[121]  Y. Mitsuhashi,et al.  Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy. , 1998, Journal of the American Academy of Dermatology.

[122]  B. Khaitan,et al.  A Comparative Study of Punch Grafting Followed by Topical Corticosteroid Versus Punch Grafting Followed by PUVA Therapy in Stable Vitiligo , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[123]  C. Antoniou,et al.  Phenylalanine plus Ultraviolet Light: Preliminary Report of a Promising Treatment for Childhood Vitiligo , 1989, Pediatric dermatology.

[124]  Lily P. H. Yang,et al.  Topical Pimecrolimus , 2009, Paediatric drugs.

[125]  J. Hercogová,et al.  Narrow‐band UV‐B micro‐phototherapy: a new treatment for vitiligo , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[126]  F. Giordano,et al.  Topical photochemotherapy of vitiligo with a new khellin formulation: preliminary clinical results , 1998 .

[127]  R. Pandey,et al.  A randomized placebo‐controlled double‐blind study of levamisole in the treatment of limited and slowly spreading vitiligo , 2005, The British journal of dermatology.

[128]  B. El-menshawi,et al.  An approach to the treatment of vitiligo by khellin. , 1982, Dermatologica.